Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
UK approves Glenmark’s novel acne treatment Winlevi
Glenmark Pharmaceuticals announced today that it has received approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi, a topical acne
WABAG secures ₹3251 crore consortium order for Sewage Treatment Plant in Saudi Arabia
Va Tech WABAG Ltd (WABAG), a leading water technology company, has secured a major consortium order worth $371 million (approximately ₹3,251 crore) from Al Haer
Regeneron Announces Positive Phase 3 Results For EYLEA HD In Retinal Vein Occlusion Treatment
(RTTNews) – Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of EYLEA HD (aflibercept) Injection 8
Regeneron Announces Positive Phase 3 Results For EYLEA HD In Retinal Vein Occlusion Treatment
(RTTNews) – Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of EYLEA HD (aflibercept) Injection 8
Eli Lilly to Acquire Versanis Bio, Maker of Obesity Treatment
Versanis shareholders could receive as much as $1.925 billion in cash, which will consist of an upfront payment and additional payments if certain milestones are
US labor agency sues Starbucks over treatment of Seattle workers By Reuters
© Reuters. FILE PHOTO: A person walks outside Starbucks headquarters in Seattle, Washington, U.S. September 12, 2022. REUTERS/Hilary Russ/File Photo By Jonathan Stempel NEW YORK
FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link